Clearbridge Health Limited
Stock Exchange of SingaporeTotal Valuation
Clearbridge Health Limited carries a market capitalization of 4.30M, placing it among publicly traded companies globally. Its enterprise value stands at 8.90M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.30M |
| Enterprise Value | 8.90M |
Share Statistics
Clearbridge Health Limited currently has 1.05B shares outstanding.
| Shares Outstanding | 1.05B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 0.41 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Clearbridge Health Limited maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 47.35, indicating elevated leverage, while an interest coverage ratio of -4.85 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.20 |
| Quick Ratio | 0.56 |
| Debt / Equity | 47.35 |
| Debt / EBITDA | -2.49 |
| Interest Coverage | -4.85 |
Financial Efficiency
| Return on Equity (ROE) | -21.82 |
| Return on Assets (ROA) | -13.13 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 13.27 |
Taxes
| Income Tax | 116,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Clearbridge Health Limited's stock has declined approximately -75% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -75% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Clearbridge Health Limited generated 21.53M in revenue and converted that into -10.51M in net income, yielding earnings per share of -0.01. EBITDA reached -9.39M, while operating income came in at -9.39M.
| Revenue | 21.53M |
| Gross Profit | 7.16M |
| Operating Income | -9.39M |
| Pretax Income | -11.43M |
| Net Income | -10.51M |
| EBITDA | -9.39M |
| EBIT | -9.39M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Clearbridge Health Limited holds 13.56M in cash and equivalents against 23.41M in total debt, resulting in a net debt position of 8.09M. Total book value stands at 48.70M, with working capital of 4.81M providing operational flexibility.
| Cash & Cash Equivalents | 13.56M |
| Total Debt | 23.41M |
| Net Debt | 8.09M |
| Equity (Book Value) | 48.70M |
| Book Value Per Share | 0.05 |
| Working Capital | 4.81M |
Cash Flow
Clearbridge Health Limited produced -8.63M in operating cash flow over the past twelve months. After subtracting -1.73M in capital expenditures, free cash flow totaled -10.36M - equivalent to -0.01 per share.
| Operating Cash Flow | -8.63M |
| Capital Expenditures | -1.73M |
| Free Cash Flow | -10.36M |
| FCF Per Share | -0.01 |
Margins
Clearbridge Health Limited operates with a gross margin of 33.25, reflecting its pricing power and cost economics. The operating margin of -43.62 and net profit margin of -48.81 provide insight into operational efficiency.
| Gross Margin | 33.25 |
| Operating Margin | -43.62 |
| Pretax Margin | -53.07 |
| Profit Margin | -48.81 |
| EBITDA Margin | -43.62 |
Scores
Clearbridge Health Limited posts an Altman Z-Score of -0.96, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.96 |